Insider trade

CFO exercised or converted 7,700 EW derivative securities

Traded Dec 9, 2025 · Filed Dec 9, 2025

Edwards LifesciencesEW

7,700
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 9, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 9, 2025

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001225208-25-009797
Filed / recorded

Dec 9, 2025, 10:01 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

Edwards Lifesciences Corp

Issuer CIK

1099800

Ticker

EW

Reporting person

Scott B. Ullem

Relationship

Officer

Officer title

CVP, Chief Financial Officer

Security

Employee Stock Option (Right to Acquire)

Table

Derivative (Table II)

Transaction date

Dec 9, 2025

Transaction code

M

Shares / units

7,700

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

39,000

Ownership form

Direct

Amendment

No

Around the same time

9mo ago

11KShares · @ $59.2567

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Officer sold ~$223K of Edwards Lifesciences

Scheduled in advance9mo ago

Officer sold ~$749K of Edwards Lifesciences

Scheduled in advance9mo ago